Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

We recently published a list of 10 Firms Crushing the Market. In this article, we are going to take a look at where Tempus AI ...

In the assessment of 12-month price targets, analysts unveil insights for Tempus AI, presenting an average target of $64.09, ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

The Chicago-based Tempus spinout called the financing round a major milestone as it expands its AI-enabled platform.

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...

GeneDx is expanding product lines, improving margins, and increasing insurance coverage, with the recent acquisition. Read ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other best performing ...

On Tuesday, the Labor Department reported that the Consumer Price Index for April rose by only 0.2 percent last month, ...

The prize is better outcomes, but the price may be sharing more personal details. Lawyers are working on the new rules ...